The Medical Research Commercialisation Fund (MRCF) Collaboration was established in 2007 as an innovative investment collaboration that invests in early stage development and commercialisation opportunities emanating from Australian medical research institutes and allied research hospitals.
The MRCF's investors are AustralianSuper, Statewide Super, HESTA, HOSTPLUS and the Australian Government under its IIF program. The MRCF acknowledges support from the Governments of Victoria, New South Wales, Western Australia, Queensland, South Australia and New Zealand. The MRCF is managed by Brandon Capital Partners, an experienced life science fund manager.
The MRCF provides its Members with a range of benefits, including:
- An early-stage fund dedicated to supporting the development and commercialisation of early-stage medical technologies;
- Access to risk-tolerant investment capital to support the development of promising technologies,
- Involvement in and exposure to the Investment Review process; and
- The investors gain access to promising technologies emanating from the Member Institutes.